Early colorectal cancer (T1 CRC) is a stage where the tumour is still limited and often treatable with less invasive methods.
ECOPOP explores whether patients can safely avoid major surgery and benefit from endoscopic treatment while maintaining the same oncological outcomes.
Some patients may avoid major abdominal surgery.
Shorter hospital stays and quicker return to normal life.
Maintaining natural bowel function whenever possible.
Clinical trials help determine the safest and most effective option.
ECOPOP aims to determine when less invasive treatment can safely replace surgery.
Early detection of colorectal cancer.
Doctors evaluate whether you can join the study.
You receive one of the carefully monitored treatment options.
Your health and outcomes are monitored over time.
Participation in ECOPOP gives access to modern treatment strategies under close medical supervision. The goal is to reduce treatment burden while maintaining safety and effectiveness.